Envestnet Portfolio Solutions Inc. Raises Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Envestnet Portfolio Solutions Inc. grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 82.9% during the fourth quarter, Holdings Channel reports. The fund owned 15,901 shares of the medical instruments supplier’s stock after purchasing an additional 7,206 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in DENTSPLY SIRONA were worth $302,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in XRAY. Nordea Investment Management AB grew its stake in DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock worth $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after buying an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock worth $45,611,000 after acquiring an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in DENTSPLY SIRONA by 1.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after acquiring an additional 35,360 shares during the period. Finally, Barclays PLC lifted its position in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after acquiring an additional 54,920 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 0.3 %

Shares of XRAY stock opened at $15.64 on Friday. The company has a 50 day simple moving average of $17.70 and a two-hundred day simple moving average of $20.26. The stock has a market cap of $3.11 billion, a P/E ratio of -7.56, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12 month low of $14.78 and a 12 month high of $33.42. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.09%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.52% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on XRAY. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Evercore ISI reissued an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Mizuho reduced their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research note on Thursday, March 13th. Finally, UBS Group cut their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.